Mediclarum
Medicine passport

Deferasirox 250 mg

The same active substance, strength and form as listed by each country’s medicines regulator. For showing a pharmacist abroad.

Active substance
Deferasirox
Strength
250 mg
Form
Tablet, for Suspension
ATC code
Not stated by the register
Registered in
United States · Alembic Pharmaceuticals Inc.
Prescription
Prescription only
NDC
62332-325

Source: NDC Directory · 2026-09-13

Not a prescription. Not a statement that these products are interchangeable. Products are matched on active substance, strength and kind of form only. Other ingredients, release, approved uses and the dose on the box can differ. A pharmacist or doctor decides whether one can replace another.

Listed in other countries

Canada 5 matching products

Name on the boxStrength and formPrescriptionHolderOfficial record
APO-DEFERASIROX250 mg · tablet for suspensionPrescription onlyApotex Inc02461552
EXJADE250 mg · tablet for suspensionPrescription onlyNovartis Pharmaceuticals Canada Inc02287439
PMS-DEFERASIROX250 mg · tablet for suspensionPrescription onlyPharmascience Inc02474336
SANDOZ DEFERASIROX250 mg · tablet for suspensionPrescription onlySandoz Canada Incorporated02464462
TARO-DEFERASIROX250 mg · tablet for suspensionPrescription onlyTaro Pharmaceuticals Inc02463539

Source: Drug Product Database (Health Canada) · 2026-09-30 · Contains information licensed under the Open Government Licence – Canada.

Same active substance, but no match for this strength and form

Countries covered: United States, Bulgaria, European Union, Spain, France, Netherlands, Canada, Switzerland. A country missing from the list may still sell this medicine: Mediclarum reads only these registers.

Register data as of 2026-09-13. Mediclarum stores nothing about you for this page. https://www.mediclarum.com/us/en/medicines/deferasirox-250-mg-tablet-for-suspension-alembic-pharmaceuticals-inc